Transplantation, HomologousHematopoietic Stem Cell TransplantationBone MarrowBone Marrow TransplantationBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation ConditioningHematologic NeoplasmsGraft SurvivalHematopoietic Stem CellsTransplantation ChimeraBone Marrow DiseasesTransplantation, IsogeneicBone Marrow ExaminationLeukemiaWhole-Body IrradiationHistocompatibilityAnemia, AplasticHematopoiesisBone Marrow NeoplasmsT-LymphocytesTissue DonorsMice, Inbred C57BLGranulocyte Colony-Stimulating FactorIsoantigensAntigens, CD34RecurrenceBone Marrow PurgingLymphocyte Culture Test, MixedCyclophosphamideTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem Cell MobilizationLeukemia, Myeloid, AcuteCombined Modality TherapyRadiation ChimeraGraft vs Tumor EffectRemission InductionSpleenHistocompatibility TestingStem Cell TransplantationBusulfanLymphoma, Non-HodgkinImmunosuppressionMultiple MyelomaTime FactorsMice, Inbred BALB CMelphalanColony-Forming Units AssayGraft vs Host ReactionGraft vs Leukemia EffectCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsSkin TransplantationFlow CytometryCell DifferentiationSurvival AnalysisMyelodysplastic SyndromesLymphocyte DepletionRetrospective StudiesGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte ActivationNeoplasm, ResidualTransplantation ImmunologyImmunosuppressive AgentsCytotoxicity, ImmunologicCytarabineAcute DiseaseBlood Component RemovalLeukocyte TransfusionCell SeparationSurvival RateLeukemia, MyeloidStromal CellsCarmustineLymphocytesMice, Inbred StrainsImmunophenotypingEtoposideAntigens, CDMice, Inbred C3HDendritic CellsLeukapheresisChimeraHLA AntigensHematologic DiseasesThymus GlandOpportunistic InfectionsImmune ToleranceMyeloablative AgonistsHodgkin DiseaseSalvage TherapyAntibodies, MonoclonalActuarial AnalysisInfectionGranulocytesVidarabine